Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome versus ropivacaine for transversus thoracic plane block in median sternotomy cardiac surgery
ChiCTR2400092693Phase 4Recruiting
- Sponsor
- Second People's Hospital of Anhui Province
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of liposomal bupivacaine and ropivacaine in postoperative pain (2 arms), sponsored by Second People's Hospital of Anhui Province. Primary endpoints: VAS pain score at rest, VAS pain score during movement and 4 more. Started Nov 2024; status: recruiting.
02
Drugs
liposomal bupivacaineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400092693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092693.